| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Jacobson Mark L. serves as a Chief Operating Officer at AXSM. Across recent SEC filings that breaks down to 0 buys and 13 sells. Those positions are worth an estimated $130K at current prices.
Historically, Jacobson Mark L.'s trades have earned a below-average insider score of 26/100 across 8 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -68.4%.
The biggest single holding is AXSM (~$130K) as Chief Operating Officer. The recent filings there lean toward selling, a net 251,895 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,000 | $208.65 | $2,086,500.00 | -100% | - | - | |
| May 5, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 4,750 | $227.95 | $1,082,770.92 | -100% | -5.4% | - | |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 35,378 | $161.88 | $5,726,990.64 | -100% | +43.7% | - | |
| Sep 22, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 10,000 | $115.96 | $1,159,600.00 | -100% | +31.7% | +72.9% | |
| Sep 16, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 45,783 | $114.48 | $5,241,126.77 | -100% | +28.2% | +85.8% | |
| Jun 9, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 25,000 | $110.44 | $2,761,000.00 | -81.2% | +17.7% | +123.6% | |
| May 28, 2025 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 40,673 | $104.07 | $4,232,636.18 | -87.6% | +17.6% | +126.1% | |
| Aug 9, 2024 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 47,739 | $84.26 | $4,022,488.14 | -89.2% | +9.2% | +26.1% | |
| May 29, 2024 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 7,910 | $74.31 | $587,813.46 | -57.8% | +18.2% | +39.1% | |
| Apr 1, 2024 | AXSM Axsome Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 24,662 | $77.24 | $1,904,942.20 | -100% | +5.2% | +45.0% |